Antonio Richetta

7PUBLICATIONS
68CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChiropracticPharmacogenomicsPhysiotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Jun 27, 2025
Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real-Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy.

Giacomo Caldarola, Annunziata Dattola, Nicoletta Bernardini

|Feb 27, 2024
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).

Diego Orsini, Giacomo Caldarola, Annunziata Dattola

|Jun 16, 2022
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year.

Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini

|Nov 26, 2021
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy.

Giuseppe Argenziano, Paolo Amerio, Maria Grazia Aragone

|Jul 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.

Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini

Pageof 2

Frequent Collaborators

4 joint publications

Claudio Bonifati

3 joint publications

Giacomo Caldarola

3 joint publications

Gaia Moretta

3 joint publications

Ketty Peris